|
1
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moore MJ, Goldstein D, Hamm J, Figer A,
Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, et al:
Erlotinib plus gemcitabine compared with gemcitabine alone in
patients with advanced pancreatic cancer: A phase III trial of the
National Cancer Institute of Canada Clinical Trials Group. J Clin
Oncol. 25:1960–1966. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bouhifd M, Hartung T, Hogberg HT,
Kleensang A and Zhao L: Review: Toxicometabolomics. J Appl Toxicol.
33:1365–1383. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cuperlović-Culf M, Barnett DA, Culf AS and
Chute I: Cell culture metabolomics: Applications and future
directions. Drug discovery today. 15:610–621. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Theodoridis GA, Gika HG, Want EJ and
Wilson ID: Liquid chromatography-mass spectrometry based global
metabolite profiling: A review. Anal Chim Acta. 711:7–16. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Freedman VH and Shin SI: Cellular
tumorigenicity in nude mice: Correlation with cell growth in
semi-solid medium. Cell. 3:355–359. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matuszewski BK, Constanzer ML and
Chavez-Eng CM: Strategies for the assessment of matrix effect in
quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem.
75:3019–3030. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kerner J and Hoppel C: Fatty acid import
into mitochondria. Biochim Biophys Acta. 1486:1–17. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zammit VA, Ramsay RR, Bonomini M and
Arduini A: Carnitine, mitochondrial function and therapy. Adv Drug
Deliv Rev. 61:1353–1362. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Medina MA, Sánchez-Jiménez F, Márquez J,
Quesada Rodríguez A and de Núñez Castro I: Relevance of glutamine
metabolism to tumor cell growth. Mol Cell Biochem. 113:1–15. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sasada S, Miyata Y, Tsutani Y, Tsuyama N,
Masujima T, Hihara J and Okada M: Metabolomic analysis of dynamic
response and drug resistance of gastric cancer cells to
5-fluorouracil. Oncol Rep. 29:925–931. 2013.PubMed/NCBI
|
|
13
|
Staubert C, Bhuiyan H, Lindahl A, Broom
OJ, Zhu Y, Islam S, Linnarsson S, Lehtiö J and Nordström A: Rewired
metabolism in drug-resistant leukemia cells: A metabolic switch
hallmarked by reduced dependence on exogenous glutamine. J Biol
Chem. 290:8348–8359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Serizawa M, Kusuhara M, Zangiacomi V,
Urakami K, Watanabe M, Takahashi T, Yamaguchi K, Yamamoto N and Koh
Y: Identification of metabolic signatures associated with erlotinib
resistance of non-small cell lung cancer cells. Anticancer Res.
34:2779–2787. 2014.PubMed/NCBI
|
|
15
|
Fujimura Y, Ikenaga N, Ohuchida K,
Setoyama D, Irie M, Miura D, Wariishi H, Murata M, Mizumoto K,
Hashizume M and Tanaka M: Mass spectrometry-based metabolic
profiling of gemcitabine-sensitive and gemcitabine-resistant
pancreatic cancer cells. Pancreas. 43:311–318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ripps H and Shen W: Review: Taurine: A
‘very essential’ amino acid. Mol vis. 18:2673–2686. 2012.PubMed/NCBI
|
|
17
|
Bellance N, Pabst L, Allen G, Rossignol R
and Nagrath D: Oncosecretomics coupled to bioenergetics identifies
α-amino adipic acid, isoleucine and GABA as potential biomarkers of
cancer: Differential expression of c-Myc, Oct1 and KLF4 coordinates
metabolic changes. Biochim Biophys Acta. 1817:2060–2071. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peters MA, Walenkamp AM, Kema IP, Meijer
C, de Vries EG and Oosting SF: Dopamine and serotonin regulate
tumor behavior by affecting angiogenesis. Drug Resist Updat.
17:96–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Beltowski J and Kedra A: Asymmetric
dimethylarginine (ADMA) as a target for pharmacotherapy. Pharmacol
Rep. 58:159–178. 2006.PubMed/NCBI
|
|
20
|
Davids M, Swieringa E, Palm F, Smith DE,
Smulders YM, Scheffer PG, Blom HJ and Teerlink T: Simultaneous
determination of asymmetric and symmetric dimethylarginine,
L-monomethylarginine, L-arginine and L-homoarginine in biological
samples using stable isotope dilution liquid chromatography tandem
mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci.
900:38–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martens-Lobenhoffer J and Bode-Böger SM:
Quantification of L-arginine, asymmetric dimethylarginine and
symmetric dimethylarginine in human plasma: A step improvement in
precision by stable isotope dilution mass spectrometry. J
Chromatogr B Analyt Technol Biomed Life Sci. 904:140–143. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li H, Zhou Y, Zhao A, Qiu Y, Xie G, Jiang
Q, Zheng X, Zhong W, Sun X, Zhou Z and Jia W: Asymmetric
dimethylarginine attenuates serum starvation-induced apoptosis via
suppression of the Fas (APO-1/CD95)/JNK (SAPK) pathway. Cell Death
Dis. 4:e8302013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoshimatsu M, Toyokawa G, Hayami S, Unoki
M, Tsunoda T, Field HI, Kelly JD, Neal DE, Maehara Y, Ponder BA, et
al: Dysregulation of PRMT1 and PRMT6, Type I arginine
methyltransferases, is involved in various types of human cancers.
Int J Cancer. 128:562–573. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cummings BS: Phospholipase A2 as targets
for anti-cancer drugs. Biochem Pharmacol. 74:949–959. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tripathi P, Kamarajan P, Somashekar BS,
MacKinnon N, Chinnaiyan AM, Kapila YL, Rajendiran TM and
Ramamoorthy A: Delineating metabolic signatures of head and neck
squamous cell carcinoma: Phospholipase A2, a potential therapeutic
target. Int J Biochem Cell Biol. 44:1852–1861. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iorio E, Mezzanzanica D, Alberti P,
Spadaro F, Ramoni C, D'Ascenzo S, Millimaggi D, Pavan A, Dolo V,
Canevari S and Podo F: Alterations of choline phospholipid
metabolism in ovarian tumor progression. Cancer Res. 65:9369–9376.
2005. View Article : Google Scholar : PubMed/NCBI
|
